CardioGenics (OTCMKTS:CGNH) Stock Price Passes Above 200 Day Moving Average – Here’s Why

CardioGenics Holdings Inc. (OTCMKTS:CGNH – Get Free Report)’s share price crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $0.00 and traded as high as $0.0001. CardioGenics shares last traded at $0.0001, with a volume of 360 shares.

CardioGenics Stock Performance

Get CardioGenics alerts:

About CardioGenics

(Get Free Report)

CardioGenics Holdings, Inc (OTCMKTS: CGNH) is a clinical diagnostics company specializing in the development, production and commercialization of immunoenzymatic assay kits and instruments for the detection and monitoring of cardiovascular disease. The company’s core focus lies in high-sensitivity cardiac biomarkers, which support early diagnosis of myocardial infarction, heart failure and related conditions. CardioGenics leverages proprietary antibody technology and assay platforms to deliver quantitative test results in clinical laboratory settings.

Headquartered in the United States, CardioGenics serves healthcare providers and diagnostic laboratories globally through a combination of direct sales channels and distribution partners.

Further Reading

• Five stocks we like better than CardioGenics
• SpaceX: Love the Company, But the Stock Is a Harder Call
• Ulta’s Growth Is Real, But So Are the Risks
• BWX Technologies Is Turning the AI Power Problem Into a Nuclear Growth Story
• Meta’s Earnings Drop Shows Wall Street Wants More Than Ad Growth

Receive News & Ratings for CardioGenics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CardioGenics and related companies with MarketBeat.com's FREE daily email newsletter.